Brent Meadows

Chief Business Officer Senovia Biosciences

Seminars

Thursday 29th October 2026
Unlocking the Potential of Ketosis to Enhance Effective, Maintainable Weight Loss
2:30 pm
  • Optimising external ketones for therapeutic use to enhance energy expenditure
  • Delivering high-quality weight loss with oral ketone therapy SNV-101 by reducing fat mass while combating comorbidity markers and preserving lean muscle
  • Exploring the use of ketone therapeutics in combination with GLP-1 therapeutics to improve long-term durability and minimize post GLP-1 weight regain
Thursday 29th October 2026
Panel Discussion: Evaluating Opportunities to Improve Long-Term Weight Loss Management
3:00 pm
  • Decreasing BMI and pricing barriers to patient access of obesity and weight loss medication
  • Exploring therapeutic and non-therapeutic methods to ensure weight maintenance beyond initial therapeutic application
Brent Meadows